3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION

Size: px
Start display at page:

Download "3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION"

Transcription

1 1. PURPOSE It is the goal of UCB, Inc. (UCB) to ensure that its marketing and promotional activities comply with all applicable state and federal laws. In addition, UCB Inc. endeavors to conform to pertinent industry guidance, the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals, the U.S. Department of Health and Human Services Office of the Inspector General (OIG) Guidance to the pharmaceutical industry, and the Accreditation Council for Continuing Medical Education (ACCME) standards for industry support of continuing medical education. This SOP describes the policies and procedures to be followed in initiating, documenting, and operating UCB Inc. speaker training programs. 2. SCOPE This SOP applies to all speaker training programs run by any UCB business unit or copromotion partner, including third party vendors and applies to health care professionals (HCPs) who provide speaker program services in the United States, in accordance with the Promotional Peer-to-Peer Programs SOP. 3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION There are no significant hazards or special instructions relating to the arrangements described that need to be detailed in this SOP. 4. RESPONSIBILITIES Business Unit Product Manager Obtaining review and approvals for all speaker training activities and revisions from the Business Unit Management team (with corresponding Legal support), Professional Education and Compliance. Selecting and coordinating third party vendors for speaker training programs. Ensuring that all speaker training program materials are appropriately reviewed and approved by UCB Review Committee. Ensures all training activities align with UCB Compliance policy and procedures. Compliance Reviewing and approving training plans. Providing and/or delivering compliance related materials for training. Monitoring speaker training activities to ensure compliance with this procedure. Page 1 of 9

2 Review Committee Reviewing and approving training content. Medical Affairs Reviewing and approving all CVs for nominated speakers. Legal Reviews and approves speaker contract templates and modifications. Professional Education (working in partnership with any third party vendors) Obtaining nominated speaker CV approvals from Medical Affairs. Ensuring that documentation of training attendance, records of attendance compensation and expense reimbursement, and signed contracts are maintained in a central repository. 5. PROCEDURE 5.1 Key Points In addition to following the procedures set forth in this SOP, speaker training programs must also comply with all UCB policies and procedures governing the engagement of HCPs. Please see SOPs: U.S. Compliance - Engaging HCPs/HCIs in Fees for Service Arrangements; Fair Market Value. The purpose of speaker training is to train medical professionals to speak for UCB, not as a mechanism to establish or maintain a relationship with or gain access to the participants. Speaker training may not be used as a promotional tool, an opportunity to discuss offlabel uses of UCB products, or as a reward or inducement for the prescription, use or recommendation of UCB products. Accordingly, it is never appropriate to conduct a return on investment ( ROI ) analysis or analyze the impact of attending speaker training on the prescribing habits of participants. Speakers must be selected based on their clinical expertise, public speaking skills, and experience. Only the number of speakers reasonably needed to fulfill UCB s speaking program needs will be selected and trained. Prior to being trained as a speaker, each HCP must have a fully executed contract in place and a completed W-9 form on file with Professional Education. Prior to making presentations on behalf of UCB, all HCPs making such presentations must complete training on content of promotional presentation and UCB Compliance Page 2 of 9

3 requirements for promotional programs. Speaker training must be renewed at least annually, unless UCB Compliance grants an exception, and more often if there are significant changes to the approved speaking materials (e.g., promotional slide deck) or product labeling. Speaker training is appropriate if there is a genuine intention to utilize the speaker in the twelve-month period following the training for the minimum number of programs set forth in the annual program plans. Information and materials disseminated at speaker training programs must be limited to those that will facilitate the training and preparation of speakers to make presentations on UCB s behalf. This information must be approved by the Review Committee prior to speaker training programs. 5.2 Types of Speaker Training Programs Formal group speaker training should generally be conducted no more than once a year. In certain circumstances, such as a substantial or material change to the prescribing information, speaker training may occur more frequently. Documented prior approval of the training plan by Compliance is required before conducting such training. Live Speaker Training Programs - Speakers receive training through live, in-person programs. Electronic training resources - Web-based training that is provided as primary or supplemental training. One-on-one speaker training - In exceptional circumstances when a speaker is unable to attend the speaker training program, a Medical Science Liaison, after advance approval by their respective Medical Director and UCB Compliance, may jointly with the Business Unit Product Manager train the HCP on scientific and clinical information related to the promotional presentation. Business Unit Product Manager must complete a training plan prior to the activity and post training provide documentation validating training occurred. 5.3 Approval of Training Plan As specific training activities are planned, training activities where HCP s will be providing and/or presenting to other nominated Speakers must be reviewed and approved by Compliance using an Activity Notification Form. The details of the specific activity will be compared against the annual program plans (as described in the Promotional Speaker Programs SOP) to ensure consistency. The Business Unit Program Manager should provide details for: Training agenda and dates Training delivery method (including any required independent study) Page 3 of 9

4 Location/venue for training and rationale Total number of speakers to be invited for training Speaker compensation for training (as applicable) Trainers for event and proposed fees (as applicable) The agenda, venue, selection of participants and other details for all speaker training programs must be designed to meet the purpose of training speakers on UCB s products and compliance policies. The number of participants invited to speaker training should reflect the number of speakers UCB reasonably expects to use within the coming year based on the Product Team s annual speaker program plan. Prior to engaging the services of a potential speaker, all internal UCB requirements must be met (e.g. CV approved, W9 completed, confirmation that the speaker has not been excluded or disqualified, contract executed). 5.4 Content of Speaker Training Meeting All speaker training sessions must include subject matter training, training on the compliance requirements of the FDA with respect to promotion of pharmaceutical products, and UCB compliance guidelines including the following: Requirements relating to the appropriate use of UCB-approved slides Requirement that presentations be consistent with the product s approved prescribing information Requirements related to appropriately balancing efficacy claims with related important safety information Requirement to present objective, balanced, and non-misleading information Appropriate manner of handling unsolicited questions about off-label use of UCB products Requirement to disclose to presentation attendees that the speaker is presenting on behalf of UCB and that UCB is sponsoring the presentation. Information provided at speaker training sessions should be directly related to the topics on which the individuals will be presenting, including the slides which will be used as the basis of the speakers presentations. All training materials (e.g., slide kits, instructions) should be submitted to the appropriate Review Committee for approval in advance of their use. Page 4 of 9

5 5.4.1 UCB Personnel Involvement in Training Programs UCB employee attendance at speaker training meetings will be limited to individuals who are directly involved in delivery of the training material content and individuals necessary to facilitate the training session and learn about conducting future programs. In general, sales specialists and their direct managers are prohibited from attending speaker training sessions, unless Compliance approval is provided in advance. No employee, regardless of role, is permitted to engage in product details or sales activities during a speaker training activity. 5.5 Compensation, Expenses and Venue Compensation Compensation for participating in speaker training should be reasonable and represent fair market value for the time commitment of the trainee. All speakers will be paid according to a pre-set rate structure determined by UCB. Speakers may not receive any type of compensation for one-on-one training Reimbursement for Travel, Meals and Other Expenses UCB may pay for the reasonable travel, lodging, meals and other reasonable expenses of speakers attending a UCB speaker training session. The number of nights of lodging paid by UCB may not exceed the number necessary for the speaker training. If a meeting ends after 3 p.m. or there are no reasonable flights available after the ending time of the meeting, UCB may pay for the lodging for that night. UCB s policy requires that meal expenses in connection with speaker training programs adhere to the following limits, including food, beverage, tax and tip: Breakfast: $25 per person Lunch: $50 per person Dinner: $125 per person UCB may not pay for the travel, incremental lodging, meals, or other expenses of anyone accompanying a HCP speaker trainee. Additional information regarding venue and meals is set forth in the policy U.S. Meals and Educational Materials for Healthcare Professionals and Customers Venue/Entertainment for Live Speaker Training Meetings Live speaker training meetings must be held in locations that are conducive to the business purpose of the meeting. The venue should not be selected based on the existence or quality of amenities, but rather upon proximity to attendees or Page 5 of 9

6 transportation, quality and cost of meeting rooms and business support, and other business related factors. Resorts or luxury hotels are not appropriate venues. Recreation and entertainment is strictly prohibited in connection with speaker training sessions. Speakers may not bring guests to speaker training sessions or Company organized meals and UCB will not pay for any expenses associated with a guest of a speaker. Additional information regarding venue and meals is set forth in the policy U.S. Meals and Educational Materials for Healthcare Professionals and Customers. 5.6 Documentation, Record Maintenance and Retention All records, information and deliverables related to this procedure will be retained for a period of six (6) years or longer if required by applicable law, contract or regulatory requirement. Records related to this procedure will be maintained by the activity owner unless otherwise specifically directed by the Legal Department. For GxP records retention refer to Corporate SOP Global Archive Procedure for Critical Records. All trainees must sign a UCB speaker contract. Copies of the contracts must be submitted to Professional Education and will be maintained on file in a central repository. Documentation will be maintained for each speaker training session, including the agenda, training materials, faculty list, and list of trainees. Each contracted HCP must certify to training completion and such certifications will be archived by Professional Education. Such certification may be included in the training completion documentation and shall include a statement that the speaker attended and received all required training, that he/she understood such training and had opportunity to ask questions regarding the training and information contained therein, and that he/she agrees to abide by Company policies and procedures. Compensation for participation in speaker training will be disclosed as required by federal and/or applicable state law. HCPs may not condition their agreement to attend speaker training on the nondisclosure of this information. Professional Education, with support from any third party vendors, will maintain a system to document and track: Identification and selection of speaker trainees Verification of each individual s attendance at training, the date, and the topic for all training mediums HCP trainee certifications regarding completion of training (which may be included in the training documentation) Page 6 of 9

7 Signed contracts for trainees, approved CVs and W9 forms Compensation and expense reimbursement paid to each trainee 6. ABBREVIATIONS AND DEFINITIONS Abbreviations and definitions, used in this document, are in accordance with the UCB Glossary. To the extent that these definitions differ from those contained in the UCB Glossary, these definitions will take precedence for the purpose of this policy / procedure. 6.1 Abbreviations FDA Food and Drug Administration FMV Fair Market Value CV Curriculum vitae HCP Health Care Professional 6.2 Definitions Fair Market Value Healthcare Professional The price, expressed in terms of cash equivalents, at which property would change hands between a hypothetical willing and able buyer and a hypothetical willing and able seller, acting at arm s length in an open and unrestricted market, whether neither is under compulsion to buy or sell and when both have reasonable knowledge of the relevant facts 1. Any person that is a member of the medical, dental, pharmacy or nursing professions or any other person who, in the course of his or her professional activities, may directly or indirectly prescribe, purchase, supply, recommend, administer or arrange for the use of a medicinal product. Page 7 of 9

8 7. RELATED DOCUMENTS 7.1 Associated Documents N/A 7.2 References sop , Retention Periods for GxP Records sop , U.S. Compliance - Engaging HCPs/ HCIs/Patients/Caregivers in Fees for Service Arrangements sop , Promotional Peer-to-Peer Programs gov , Fair Market Value gov , U.S. Meals and Educational Materials for Healthcare Professionals and Customers 1 American Society of Appraisers Business Valuation Standards Glossary ; Approved June 2005 Copyright 2005, American Society of Appraisers. 8. LIST OF APPENDICES N/A 9. SOP HISTORY Supersedes SOP(s) (SOP number and version) UCBCOM-SOP-005 Migration into MIKADO CD Changes sop v1.0 sop v2.0 sop v3.0 sop v4.0 sop v5.0 Periodic revision, format change Updated due to changing business requirements Revised section 6.3 to provide clarity around need for activity notification (needs assessment) approvals. Section 5.2 improving clarity of process for MSL one:one training. Section 5.2 One-on-one speaker training rules for engagement of MSLs in the activity. Section 6.2 definition for HCP Page 8 of 9

9 DOCUMENT APPROVAL ELECTRONIC SIGNATURES Signed by Meaning of Signature Server Date (dd-mmm-yyyy HH:mm:ss TZ) GRAVES Mark Subject Matter Expert Approval 10-Sep :00:25 CEST JEFFORDS SCHENCK Jan Author Approval 10-Sep :15:39 CEST DAVIS Clive Management Approval 13-Sep :37:08 CEST HELLING Douglas Legal Approval 15-Sep :05:54 CEST DHALLA Anisa Compliance Approval 29-Sep :04:17 CEST Page 9 of 9

U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT

U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT Effective: January 1, 2009 U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT January 1, 2009 I. INTRODUCTION Table of Contents II. COMPLIANCE

More information

Business Conduct Standards for Interactions with Healthcare Professionals. Pocket Guide for U.S. Sales Professionals. Do The Right Thing

Business Conduct Standards for Interactions with Healthcare Professionals. Pocket Guide for U.S. Sales Professionals. Do The Right Thing Business Conduct Standards for Interactions with Healthcare Professionals Pocket Guide for U.S. Sales Professionals Do The Right Thing As Amgen s Vice President of Sales and Marketing Operations and Planning,

More information

Amgen GLOBAL CORPORATE COMPLIANCE POLICY

Amgen GLOBAL CORPORATE COMPLIANCE POLICY 1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,

More information

Keeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct

Keeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct Keeping our Focus: Compliance Summary for Customers and Health Care Professionals Understanding the Olympus Health Care Compliance Code of Conduct Introduction Olympus Corporation of the Americas ( Olympus

More information

CONDUCTING BUSINESS WITH HEALTH CARE PROFESSIONALS.

CONDUCTING BUSINESS WITH HEALTH CARE PROFESSIONALS. A. General. CONDUCTING BUSINESS WITH HEALTH CARE PROFESSIONALS. This policy governs the interactions between Company personnel and health care professionals. The term health care professional means any

More information

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD mseligman@pri-medinstitute.org DISCLAIMER: For informational

More information

Code on Interactions with Healthcare. Professionals

Code on Interactions with Healthcare. Professionals Code on Interactions with Healthcare Professionals Table of Contents Preamble 1 Basis of Interactions 2 Informational Presentations by Pharmaceutical Company Representatives and Accompanying Meals 3 Prohibition

More information

PhRMA Code on Interactions with Healthcare Professionals

PhRMA Code on Interactions with Healthcare Professionals PhRMA Code on Interactions with Healthcare Professionals Preamble The Pharmaceutical Research and Manufacturers of America (PhRA4.A) represents research-basedpharmaceutical and biotechnology companies.

More information

Globus Medical, Inc. Code of Ethics

Globus Medical, Inc. Code of Ethics Globus Medical, Inc. Code of Ethics 1. Introduction In performing their duties for Globus Medical, Inc. ( Globus ), each employee shall maintain the highest standards of honest and ethical conduct in all

More information

CORPORATE INTEGRITY AGREEMENT

CORPORATE INTEGRITY AGREEMENT CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND GLAXOSMITHKLINE LLC I. PREAMBLE (GSK) hereby enters into this Corporate Integrity

More information

Global Policy on Interactions with Healthcare Professionals

Global Policy on Interactions with Healthcare Professionals Global Policy on Interactions with Healthcare Professionals Global Policy on Interactions with Healthcare Professionals Pfizer is committed to collaborating with physicians and other healthcare professionals,

More information

The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009

The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009 The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009 Purpose All healthcare professionals and institutions have

More information

Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402

Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402 Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402 I. INTRODUCTION Bayer HealthCare LLC [including Bayer HealthCare LLC Dermatology Division

More information

Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy. Introduction

Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy. Introduction Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy Introduction The faculty 1 and medical students of the Joan C. Edwards School of Medicine (SOM) have responsibilities

More information

POLICY ON INTERACTIONS WITH HEALTHCARE PROFESSIONALS

POLICY ON INTERACTIONS WITH HEALTHCARE PROFESSIONALS POLICY ON INTERACTIONS WITH HEALTHCARE PROFESSIONALS Table of Contents Interaction with Healthcare Professionals... 2 Definitions... 2 Basic Requirements for all Interactions with Healthcare Professionals...

More information

University of Cincinnati College of Medicine

University of Cincinnati College of Medicine University of Cincinnati College of Medicine Policy Policy and Guidelines for Industry Relationships Policy and Guidelines for Industry Relationships FAQ Date Updated Page 5/14/2008 2 -- 8 NB: The Institute

More information

Effective March 23, 2015

Effective March 23, 2015 I. Goal and Scope CODE OF ETHICS ON INTERACTIONS WITH HEALTH CARE PROFESSIONALS Effective March 23, 2015 Symmetry Surgical Inc. ( Symmetry ) has an obligation to facilitate ethical interactions between

More information

How To Accredit A Continuing Education Program

How To Accredit A Continuing Education Program POLICY AND PROCEDURES OFFICE OF EXECUTIVE PROGRAMS Accreditation -- Continuing Education Table of Contents PURPOSE...1 BACKGROUND...1 POLICY...3 RESPONSIBILITIES...7 PROCEDURES...7 REFERENCES...8 DEFINITIONS...8

More information

MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations

MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations Melissa J. Lopes, Deputy General Counsel Massachusetts Department of Public Health Marissa Seligman,

More information

Clinical Communications Programs with Healthcare Professionals and Patients

Clinical Communications Programs with Healthcare Professionals and Patients A Multichannel Approach Clinical Communications Programs with Healthcare Professionals and Patients A Publicis Touchpoint Solutions White Paper Best Practices Series 2011 Publicis Touchpoint Solutions,

More information

Determining the Bona Fide Nature of Fee-for-Service Arrangements

Determining the Bona Fide Nature of Fee-for-Service Arrangements Determining the Bona Fide Nature of Fee-for-Service Arrangements Mark DeWyngaert, PhD, MBA John Moose, MBA, CPA, ABV Elizabeth Gluck, Esq. September 27, 2012 About the Speakers Elizabeth Gluck, King &

More information

Guidance Document Questions & Answers (Q&As) on the MedTech Europe Code of Ethical Business Practice

Guidance Document Questions & Answers (Q&As) on the MedTech Europe Code of Ethical Business Practice Guidance Document Questions & Answers (Q&As) on the MedTech Europe Code of Ethical Business Practice INTRODUCTION Aims and Principles of the Code 2 December 2015 Q1: Does the definition of Healthcare Professional

More information

Heraeus Medical Code of Conduct on Interactions with Health Care Professionals

Heraeus Medical Code of Conduct on Interactions with Health Care Professionals Heraeus Medical Code of Conduct on Interactions with Health Care Professionals effective 13 th July 2009 The Heraeus Medical Code of Conduct is based on the Advamed Code of Ethics and influenced by Codes

More information

SUCAMPO PHARMA AMERICAS, LLC COMPREHENSIVE COMPLIANCE PROGRAM

SUCAMPO PHARMA AMERICAS, LLC COMPREHENSIVE COMPLIANCE PROGRAM SUCAMPO PHARMA AMERICAS, LLC COMPREHENSIVE COMPLIANCE PROGRAM 1. Introduction It is the policy of Sucampo Pharma Americas, LLC, ( Sucampo or Company ) to promote our products in full compliance with law,

More information

State Marketing Law Compliance: Implications of Federal Sunshine Act Preemption

State Marketing Law Compliance: Implications of Federal Sunshine Act Preemption State Marketing Law Compliance: Implications of Federal Sunshine Act Preemption Ronald L. Wisor, Partner February 19, 2013 Health / United States Agenda Types of state marketing laws State-specific requirements

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016 Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016 AstraZeneca Österreich GmbH Schwarzenbergplatz 7, 1030 Wien Firmenbuch FN 51184x, HG Wien Contents

More information

LIBRARY GUIDE: Pharmaceutical Sales & Marketing

LIBRARY GUIDE: Pharmaceutical Sales & Marketing LIBRARY GUIDE: Pharmaceutical Sales & Marketing Page 2 Pharmaceutical Sales and Marketing Course Library Table of Contents: Courses Listed by Functional Area... 4 Basics of the PhRMA Code (PHSM01)...5

More information

STONY BROOK UNIVERSITY HOSPITAL GRADUATE MEDICAL EDUCATION POLICIES AND PROCEDURES PHARMACEUTICAL VENDOR/CORPORATION RELATIONSHIPS

STONY BROOK UNIVERSITY HOSPITAL GRADUATE MEDICAL EDUCATION POLICIES AND PROCEDURES PHARMACEUTICAL VENDOR/CORPORATION RELATIONSHIPS 1 STONY BROOK UNIVERSITY HOSPITAL GRADUATE MEDICAL EDUCATION POLICIES AND PROCEDURES POLICY: PHARMACEUTICAL VENDOR/CORPORATION RELATIONSHIPS PURPOSE To establish an institutional policy regarding institutional

More information

How to Conduct a Clinical Research Compliance Assessment

How to Conduct a Clinical Research Compliance Assessment 8 th Annual Pharmaceutical Regulatory Compliance Congress Track II Session November 8, 2007 How to Conduct a Clinical Research Compliance Assessment Elizabeth Jobes Deputy Compliance Officer Cephalon,

More information

Travel Program & Business Expense Policy Business Ethics & Vendor Relationships FAQs

Travel Program & Business Expense Policy Business Ethics & Vendor Relationships FAQs CORPORATE POLICY CREATED: REVIEWED: REVISED: Business Ethics and Vendor Relationships SCOPE: All Employees APPROVED BY: Corporate Leadership Team (CLT) FORMULATED BY: Chief Compliance Officer Reference

More information

University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents

University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial

More information

Eucomed. Code of Ethical Business Practice. Eucomed Guidelines on Interactions with Healthcare Professionals

Eucomed. Code of Ethical Business Practice. Eucomed Guidelines on Interactions with Healthcare Professionals Eucomed M e d i c a l T e c h n o l o g y Code of Ethical Business Practice Eucomed Guidelines on Interactions with Healthcare Professionals Amended September 2008 - Board approved, 11 September 2008 The

More information

University of Miami Miller School of Medicine

University of Miami Miller School of Medicine University of Miami Miller School of Medicine Policy UMMG [University of Miami Medical Group] Policy: Pharmaceutical/Device Representative Interaction Division of Continuing Medical Education Website Date

More information

Policy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions**

Policy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions** Policy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions** Approved by the SOM Committee of Chairs January 23, 2008. Approved by the COP

More information

In-house code: Specific guidelines regarding a company s own promotion. All members are requested to formulate an in-house code.

In-house code: Specific guidelines regarding a company s own promotion. All members are requested to formulate an in-house code. Comparison of the AdvaMed Code of Ethics and the Japanese JFMDA Promotion Code Executive Summary: The Japan Federation of Medical Devices Associations, (JFMDA), consists of some 20 associations representing

More information

The Chairman s Message on Health Care Compliance

The Chairman s Message on Health Care Compliance 904438_JnJ_EmpGde 9/17/09 8:37 AM Page FC2 The Chairman s Message on Health Care Compliance Johnson & Johnson is known the world over for innovative, life-saving medical products and for the values we

More information

A PASSION FOR INTEGRITY. Every Day Health Care Compliance. Code of Conduct

A PASSION FOR INTEGRITY. Every Day Health Care Compliance. Code of Conduct A PASSION FOR INTEGRITY Every Day Health Care Compliance Code of Conduct Health Care Compliance Is Everyone s Responsibility Johnson & Johnson Pharmaceutical Affiliates are known the world over for innovative,

More information

Code of Conduct. Compliance W.I.N.S Worldwide Integrity is Necessary for Success

Code of Conduct. Compliance W.I.N.S Worldwide Integrity is Necessary for Success Code of Conduct Compliance W.I.N.S Worldwide Integrity is Necessary for Success Effective February 2014 Disclaimer BEFORE YOU BEGIN You are being provided this certification to assist you in meeting your

More information

PamHa~Y"'-.~ \_-..\<J.L.'e_

PamHa~Y'-.~ \_-..\<J.L.'e_ United States Department of the Interior OFFICE OF THE SECRETARY Washington, DC 20240 2 7 2013 FINANCIAL MANAGEMENT MEMORANDUM 2013-024 (Vol. VI.B.) To: From: Subject: Assistant Secretaries Heads of Bureaus

More information

FDA & Life Sciences Practice Group. State Marketing Laws Impacting Medical Device Manufacturers. January 11, 2010

FDA & Life Sciences Practice Group. State Marketing Laws Impacting Medical Device Manufacturers. January 11, 2010 State Marketing Laws Impacting Medical Device Manufacturers January 11, 2010 For more information, contact: Seth Lundy (202) 626-2924 slundy@kslaw.com Nikki Reeves (202) 661-7850 nreeves@kslaw.com Elizabeth

More information

Law Department Policy No. L-3 Title:

Law Department Policy No. L-3 Title: I. SCOPE: Law Department Policy No. L-3 Page: 1 of 15 This policy applies to (1) Tenet Healthcare Corporation and its wholly-owned subsidiaries and affiliates (each, an Affiliate ); (2) any other entity

More information

EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS. Table of Contents

EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS. Table of Contents EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS Table of Contents EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL

More information

Fair Market Value and Payments to Healthcare Professionals How Should We Determine What We Pay? Huron Consulting Services LLC. All rights reserved.

Fair Market Value and Payments to Healthcare Professionals How Should We Determine What We Pay? Huron Consulting Services LLC. All rights reserved. Fair Market Value and Payments to Healthcare Professionals How Should We Determine What We Pay? Huron Consulting Services LLC. All rights reserved. Contact Information Debjit Ghosh Life Sciences Practices

More information

Medical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK

Medical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK Medical Science Liaison (MSL): Understanding, Engaging and Interacting Gill Logan Regional Medical Affairs Manager Takeda UK Date of upload, October 2011 Disclosures Takeda UK employee Member of the MSLA

More information

Guideline for Commercial Support for Continuing Nursing Education

Guideline for Commercial Support for Continuing Nursing Education Guideline for Commercial Support for Continuing Nursing Education Summary: The attached guidelines on "Commercial Support of Continuing Nursing Education" have been developed by the American Nurses Association

More information

Travel Policy. Finance and Accounting

Travel Policy. Finance and Accounting Finance and Accounting Policy No.: FA. 02-03-002 Effective Date: Supersedes: Publication Date: 11/17/2014 All Previous Versions 07/16/2014 1.0 Purpose This document describes the requirements for San Jose

More information

Emory University Office of Financial Aid Operating Principles for Student Loan Provider Relationships

Emory University Office of Financial Aid Operating Principles for Student Loan Provider Relationships Emory University Office of Financial Aid Operating Principles for Student Loan Provider Relationships The Office of Financial Aid is committed to ensuring compliance with federal, state and university

More information

The scope of beneficial interactions between Health Care Professionals and Companies is broad and includes interactions intended to:

The scope of beneficial interactions between Health Care Professionals and Companies is broad and includes interactions intended to: CODE OF ETHICS ON INTERACTIONS WITH HEALTH CARE PROFESSIONALS ADOPTED BY THE ADVANCED MEDICAL TECHNOLOGY ASSOCIATION I. Preamble: Goal and Scope of AdvaMed Code The Advanced Medical Technology Association

More information

Board Statute Regarding Gifts to Physicians

Board Statute Regarding Gifts to Physicians Board Statute Regarding Gifts to Physicians KRS 311.595(9), as illustrated by KRS 311.597(4), provides that it is a statutory violation, and a basis for disciplinary action against a license, for a licensed

More information

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:

More information

Industry Sponsored Satellite Symposia Information and Application

Industry Sponsored Satellite Symposia Information and Application Industry Sponsored Satellite Symposia Information and Application Dear ACOOG Annual Conference Exhibitor: Thank you for your interest in planning an Industry Supported Satellite Symposium in conjunction

More information

NYSCHP Policy on Accepting Corporate Support and Avoiding Conflicts of Interest

NYSCHP Policy on Accepting Corporate Support and Avoiding Conflicts of Interest NYSCHP Policy on Accepting Corporate Support and Avoiding Conflicts of Interest Introduction This document states NYSCHP s philosophy and guiding principles with respect to corporate support from pharmaceutical

More information

Use of Social Media by Pharmaceutical Medical Information Teams

Use of Social Media by Pharmaceutical Medical Information Teams www.arisglobal.com A White Paper Presented By ArisGlobal Use of Social Media by Pharmaceutical Medical Information Teams Ome Ogbru, PharmD, Medical Information SME What is Social Media? The Merriam-Webster

More information

INSTRUCTIONS TO JOINT PROVIDERS OF CME ACTIVITIES

INSTRUCTIONS TO JOINT PROVIDERS OF CME ACTIVITIES INSTRUCTIONS TO JOINT PROVIDERS OF CME ACTIVITIES TABLE OF CONTENTS 1. OVERVIEW AND TIMELINE... 2 2. Online Application Process... 4 3. POLICIES... 4 Use of Accreditation Statement... 4 ATS CME Mission...

More information

Continuing Medical Education Category 1 Credit Documentation Process UnityPoint Health - Des Moines

Continuing Medical Education Category 1 Credit Documentation Process UnityPoint Health - Des Moines Continuing Medical Education Category 1 Credit Documentation Process UnityPoint Health - Des Moines UnityPoint Health - Des Moines is accredited by the Iowa Medical Society (IMS) to provide continuing

More information

GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY

GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY CMA POLICY GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY The history of health care delivery in Canada has included interaction between physicians and the pharmaceutical and health supply industries;

More information

Law Department Policy No. L-4 Title:

Law Department Policy No. L-4 Title: I. SCOPE: Law Department Policy No. L-4 Page: 1 of 10 This policy applies to (1) Tenet Healthcare Corporation and its wholly-owned subsidiaries and affiliates (each, an Affiliate ); (2) any other entity

More information

GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009

GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009 Introduction GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009 Effective July 1, 2009, Vermont law bans certain gifts and

More information

Code of Business Practice

Code of Business Practice Code of Business Practice Mecomed Guidelines on Interactions with Healthcare Professionals Board approved, November 1 st, 2008 Amended version, May 2015 The MECOMED Code of Business Practice consists of

More information

General Policy Statement and Standards on Prohibition on Self-Referrals, Kickbacks and Inducements to Refer. Refer to document abstract on Pulse

General Policy Statement and Standards on Prohibition on Self-Referrals, Kickbacks and Inducements to Refer. Refer to document abstract on Pulse POLICY Department: Corporate Compliance and Audit Services Mnemonic: COM Type: S Number: LL-010 Policy Title: General Policy Statement and Standards on Prohibition on Self-rals, Kickbacks and Inducements

More information

SUBJECT: TRAVEL AND BUSINESS EXPENSE POLICY

SUBJECT: TRAVEL AND BUSINESS EXPENSE POLICY CATEGORY: Policy and Procedure PAGE: 1 of 14 This policy has been written to be consistent with the Broader Public Sector Expenses Directive effective April 1, 2011. This policy applies to all HRSRH employees,

More information

ADVAMED CODE OF ETHICS. Illustrative Best Practices Tools

ADVAMED CODE OF ETHICS. Illustrative Best Practices Tools ADVAMED CODE OF ETHICS Illustrative Best Practices Tools ADVAMED CODE OF ETHICS Illustrative Best Practices Tools Menu Charitable Donations Consulting Arrangements Demonstration and Evaluation Units Educational

More information

Summary. ViiV Healthcare Compliance Program U.S. Operations

Summary. ViiV Healthcare Compliance Program U.S. Operations ViiV Healthcare Compliance Program U.S. Operations Summary ViiV Healthcare Company (the Company or VH ) is committed to conducting its business with honesty and integrity, and with high standards for ethical

More information

Why do we have Speaker Compliance Guidelines and Training?

Why do we have Speaker Compliance Guidelines and Training? Disclaimer The views expressed in this presentation are the views of the facilitators and do not necessarily represent the views or policies of our employer. Why do we have Speaker Compliance Guidelines

More information

Emory Healthcare Policy on Relationships with Vendors, Industry and Other External Professional Relationships

Emory Healthcare Policy on Relationships with Vendors, Industry and Other External Professional Relationships Final Version 1,12,2010 Emory Healthcare Policy on Relationships with Vendors, Industry and Other External Professional Relationships 1. Scope 2. Overview 3. Applicability 4. General Policy 5. Gifts/Donations

More information

Medical Technology Industry Code of Practice (Administered by the Medical Technology Association of Australia) 9 th Edition 2015

Medical Technology Industry Code of Practice (Administered by the Medical Technology Association of Australia) 9 th Edition 2015 Medical Technology Industry Code of Practice (Administered by the Medical Technology Association of Australia) 9 th Edition 2015 MTAA Code of Practice and Explanatory Notes 31 October 2014 Page 1 of 58

More information

Africa Mathematics Project. Request for Applications

Africa Mathematics Project. Request for Applications Africa Mathematics Project Request for Applications The Africa Mathematics Project (AMP) of the Simons Foundation invites applications for grants to support mathematical activities in Africa, including

More information

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS

More information

Industry Hosted Events Space Request and Registration Form

Industry Hosted Events Space Request and Registration Form Industry Hosted Events Space Request and Registration Form In an effort to provide excellent service to The Aesthetic Meeting attendees, The Aesthetic Society is requiring all exhibiting companies register

More information

Clause 2 (Contractual Arrangements)

Clause 2 (Contractual Arrangements) Questions and Answers (Q&A) Relating to the International Medical Device Manufacturers Association (IMEDA) Code of Ethical Conduct for Interactions with Healthcare Professionals Clause 2 (Contractual Arrangements)

More information

The Danish Ethical Rules for. Promotion of Medicinal Products. towards Healthcare Professionals

The Danish Ethical Rules for. Promotion of Medicinal Products. towards Healthcare Professionals The Danish Ethical Rules for Promotion of Medicinal Products towards Healthcare Professionals Self-regulation since 1973 The Ethical Committee for the Pharmaceutical Industry in Denmark (ENLI) Unauthorised

More information

GSK Code of Practice for promotion and customer interactions

GSK Code of Practice for promotion and customer interactions GSK Code of Practice for promotion and customer interactions Effective 21 July 2014 GSK Code of Practice GSK s interaction with external communities and the marketing of our products to ensure their appropriate

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

CODE OF ETHICS. Unofficial translation Only the official texts in the Dutch or French language are authentic.

CODE OF ETHICS. Unofficial translation Only the official texts in the Dutch or French language are authentic. CODE OF ETHICS Unofficial translation Only the official texts in the Dutch or French language are authentic. Contents Preface PART I. Regulations Chapter I. Allowances and Advantages Chapter II. Scientific

More information

CODE OF ETHICS ZERO TOLERANCE - BRIBERY AND CORRUPTION ADVANTAGE

CODE OF ETHICS ZERO TOLERANCE - BRIBERY AND CORRUPTION ADVANTAGE 5682340-v1 This Code of Ethics is mandatory for H&M employees, in house working consultants, in house working staff from Temporary Agencies and similar assignments. INTRODUCTION H & M Hennes & Mauritz

More information

Work station is the place of work to which the employee is assigned, i.e. where his/her office is located.

Work station is the place of work to which the employee is assigned, i.e. where his/her office is located. POLICY Title: Travel Expense, Hospitality and Public Disclosure Policy Statement: The Board will pay hospitality and travel expenses necessarily incurred in the performance of College duties. Claimants

More information

Genentech Corporate Giving and Grants Tip Sheet Healthcare-Related Charitable Support

Genentech Corporate Giving and Grants Tip Sheet Healthcare-Related Charitable Support Genentech Corporate Giving and Grants Healthcare-Related Charitable Support Table of Contents What is Healthcare-Related Charitable Support... 2 Checklist..... 2 I. Log in... 3 II. Organization Registration

More information

The Hidden Costs of Free Lunches: Fraud and Abuse in Physician- Pharmaceutical Arrangements

The Hidden Costs of Free Lunches: Fraud and Abuse in Physician- Pharmaceutical Arrangements The Hidden Costs of Free Lunches: Fraud and Abuse in Physician- Pharmaceutical Arrangements Alice G. Gosfield* W hen it comes to physician-pharmaceutical manufacturer relationships, the old adage there

More information

B. Non-Referral Source Arrangement means an arrangement with any other person or entity not a Referral Source, as defined above.

B. Non-Referral Source Arrangement means an arrangement with any other person or entity not a Referral Source, as defined above. I. SCOPE: Page: 1 of 10 This policy applies to (1) Tenet Healthcare Corporation and its wholly-owned subsidiaries and affiliates (each, an Affiliate ); (2) any other entity or organization in which Tenet

More information

HCCA 2013 COMPLIANCE INSTITUTE ANTI-KICKBACK STATUTE 101 SEATTLE, WASHINGTON

HCCA 2013 COMPLIANCE INSTITUTE ANTI-KICKBACK STATUTE 101 SEATTLE, WASHINGTON UW MEDICINE HCAA 2013 Compliance Institute HCCA 2013 COMPLIANCE INSTITUTE ANTI-KICKBACK STATUTE 101 April 23, 2013 Robert S. Brown Senior Compliance Specialist UW Medicine Compliance SEATTLE, WASHINGTON

More information

Department of Defense INSTRUCTION

Department of Defense INSTRUCTION Department of Defense INSTRUCTION NUMBER 6000.08 January 22, 2014 USD(P&R) SUBJECT: Defense Health Program Research and Clinical Investigation Programs References: See Enclosure 1 1. PURPOSE. This instruction:

More information

OIG Provides Guidance on Internet Advertising Under the Anti-Kickback Law

OIG Provides Guidance on Internet Advertising Under the Anti-Kickback Law NUMBER 230 FROM THE LATHAM & WATKINS HEALTH CARE PRACTICE GROUP BULLETIN NO. 230 OCTOBER 25, 2002 OIG Provides Guidance on Internet Advertising Under the Anti-Kickback Law This Advisory Opinion offers

More information

Accreditation Statement...2. CME Content Validation...2. Commercial Support and Disclosure...3. Credit Certificates for CME...6

Accreditation Statement...2. CME Content Validation...2. Commercial Support and Disclosure...3. Credit Certificates for CME...6 Including Information for Provider Implementation (UMA) policies supplement the Essential Areas and Elements and result from actions taken by UMA s Accreditation Committee. These policies were developed

More information

Selecting the Right Call Center Partner

Selecting the Right Call Center Partner Text for a pull out can go heretext for a pull out can go heretext for a pull out can go Text for a pull out can go here Text for a pull out can go here Selecting the Right Call Center Partner Nine Tips

More information

CONCORDIA HEALTHCARE CORP. CODE OF CONDUCT. Message from the Chairman and Chief Executive Officer ( CEO )

CONCORDIA HEALTHCARE CORP. CODE OF CONDUCT. Message from the Chairman and Chief Executive Officer ( CEO ) CONCORDIA HEALTHCARE CORP. CODE OF CONDUCT Message from the Chairman and Chief Executive Officer ( CEO ) Dear Colleagues, The standards of ethical excellence that Concordia was founded upon remain as important

More information

OVERVIEW OF IPTR AND NON-FORMULARY PROCESS IN THE ACUTE SECTOR

OVERVIEW OF IPTR AND NON-FORMULARY PROCESS IN THE ACUTE SECTOR 5.2: POLICY FOR THE MANAGEMENT OF INDIVIDUAL PATIENT TREATMENT REQUESTS IMPORTANT NOTE: This policy document is subject to review pending the introduction of the Peer Approval Clinical System which will

More information

Complete the enrollment form on the reverse side to join Onyx 360 today.

Complete the enrollment form on the reverse side to join Onyx 360 today. Complete the enrollment form on the reverse side to join Onyx 360 today. Oncology Nurse Advocates are available Monday through Friday, from 9 am to 8 pm Eastern Standard Time at 1-855-ONYX-360 (1-855-669-9360)

More information

CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS

CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS This Second Amended and Restated Code of Business Conduct and Ethics (the Code ) sets forth legal and ethical

More information

HOPE COLLEGE TRAVEL AND ENTERTAINMENT EXPENSE POLICY

HOPE COLLEGE TRAVEL AND ENTERTAINMENT EXPENSE POLICY HOPE COLLEGE TRAVEL AND ENTERTAINMENT EXPENSE POLICY May 27, 2003 Revised June 21, 2005 Revised July 1, 2008 Table of Contents Travel and Entertainment Policy Purpose Page 3 Travel Authorization Page 4

More information

Corporate Compliance and Ethics Program Effective as adopted on February 21, 2012

Corporate Compliance and Ethics Program Effective as adopted on February 21, 2012 Corporate Compliance and Ethics Program Effective as adopted on February 21, 2012 Page 1 of 7 SECTION 1. STATEMENT OF INTENT As a specialty pharmaceutical company and diagnostic laboratory, Prometheus

More information

Yale University Open Data Access (YODA) Project Procedures to Guide External Investigator Access to Clinical Trial Data Last Updated August 2015

Yale University Open Data Access (YODA) Project Procedures to Guide External Investigator Access to Clinical Trial Data Last Updated August 2015 OVERVIEW Yale University Open Data Access (YODA) Project These procedures support the YODA Project Data Release Policy and more fully describe the process by which clinical trial data held by a third party,

More information

Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6

Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6 Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication

More information

Commercial supporters may not take the role of a non-accredited partner or participate in a joint sponsorship relationship.

Commercial supporters may not take the role of a non-accredited partner or participate in a joint sponsorship relationship. Continuing Pharmacy Education Office Commercial Support Policy Revised January 2014 The University of Arkansas for Medical Science College of Pharmacy is accredited by the Accreditation Council for Pharmacy

More information

Did the person who incurred the expenses provide the preparer with all of the

Did the person who incurred the expenses provide the preparer with all of the Hello and welcome to the Expense Preparers training presentation. It is expected that if you are reviewing this presentation, you have already reviewed the Business & Travel Expense Policy Overview presentation.

More information

Table of Contents. Introduction... 1 Commitment to Integrity... 1 The EMD Serono Code of Conduct... 2

Table of Contents. Introduction... 1 Commitment to Integrity... 1 The EMD Serono Code of Conduct... 2 CODE OF CONDUCT Table of Contents Introduction... 1 Commitment to Integrity... 1 The EMD Serono Code of Conduct... 2 Policies and Practices... 3 Employment Practices... 3 Equal Employment Opportunity...3

More information

Title: Gifts and Business Courtesies

Title: Gifts and Business Courtesies Title: Gifts and Business Courtesies Effective Date: 5/04; Rev. 5/07 POLICY: Employees, (referred to as associates at some affiliates) officers and members of the Boards of Directors of Iowa Health System

More information

CMSS Physician Payment Sunshine Act FAQs

CMSS Physician Payment Sunshine Act FAQs CMSS Physician Payment Sunshine Act FAQs These FAQs are intended as a resource for CMSS member organizations to create their own guidance document. The answers are based on the guidance that is publicly

More information

ALARIS ROYALTY CORP. TRADING AND BLACKOUT POLICY

ALARIS ROYALTY CORP. TRADING AND BLACKOUT POLICY ALARIS ROYALTY CORP. TRADING AND BLACKOUT POLICY Purpose The purpose of this Policy is to ensure compliance with applicable Canadian securities laws governing trading in securities of Alaris Royalty Corp.

More information

LIBRARY GUIDE: Medical Device Sales & Marketing

LIBRARY GUIDE: Medical Device Sales & Marketing LIBRARY GUIDE: Medical Device Sales & Marketing Page 2 Table of Contents Overview... 2 About Our Health Care Compliance Solution... 2 Our Relationship With AdvaMed... 2 Course Descriptions: Basics of the

More information

GOVERNMENT OF THE DISTRICT OF COLUMBIA Department of Health

GOVERNMENT OF THE DISTRICT OF COLUMBIA Department of Health GOVERNMENT OF THE DISTRICT OF COLUMBIA Department of Health Prescription Drug Marketing Costs A Guide for Pharmaceutical Manufacturers and Labelers Published by the District of Columbia Department of Health

More information